Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 4Recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 965Urinary Bladder Neoplasms 268Carcinoma, Renal Cell 253Kidney Neoplasms 146Breast Neoplasms 131Carcinoma, Transitional Cell 127Neoplasms 122Colorectal Neoplasms 100Ovarian Neoplasms 93Melanoma 85Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 83Neoplasm Metastasis 79Pancreatic Neoplasms 69Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 59Stomach Neoplasms 56Head and Neck Neoplasms 52Endometrial Neoplasms 50Squamous Cell Carcinoma of Head and Neck 48Esophageal Neoplasms 44Adenocarcinoma 44Testicular Neoplasms 42Carcinoma, Hepatocellular 41Sarcoma 39Triple Negative Breast Neoplasms 34Liver Neoplasms 32Disease 31Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Interventions

tislelizumab 1Rutin 1Neoadjuvant Therapy 1Gemcitabine 1Cystectomy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Muscle Invasive Bladder Cancer × Genitourinary × Clear all
NCT07202819 2025-10-02

"NAC-MRI"

Assiut University

Phase NA Recruiting
76 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT06916494 2025-04-10

Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer

First Affiliated Hospital of Chongqing Medical University

Phase 1 Recruiting
10 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡